Events

Smart Specialisation for the Recovery online workshop
APR
Thu
15
10:00 - 13:15

This was 5 years ago

Location

Online

Programmes
JRC

The Joint Research Centre (JRC) and the European Committee of the Regions (CoR) will jointly organise an online workshop on Smart Specialisation on 15 April at 10:00-13:15. 

This workshop aims to explore how Smart Specialisation can be an effective tool to help territories recover from the current pandemic-induced crisis and discover new opportunities for more sustainable and inclusive economies.

This workshop offers a unique forum for discussing concrete achievements, good practices, and challenges related to implementing the Smart Specialisation policy in EU regions. It seeks to foster a dialogue between practitioners, policy-makers and researchers.

More information on this event and registration can be found here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.